Dr. Moshe Inbar is a leading oncologist in Israel, renowned for his expertise in radiation oncology and modern cancer treatment techniques such as CyberKnife for lung tumors. With an impressive 40-year career, Dr. Inbar’s journey began at Hadassah University Hospital, where he completed his specialization and research training. He served as the chairman of oncology at Sackler University and gained international recognition through his roles at prestigious institutions like the Royal Marsden Hospital in London, Harvard Medical School, and Memorial Sloan Kettering Cancer Center in New York. His global collaborations and extensive clinical experience have made him one of the top, most famous oncologists in Israel. Dr. Moshe Inbar’s commitment to advancing cancer treatment through research, education, and innovative procedures distinguishes him as a popular and highly respected figure in the medical community.
Dr. Moshe Inbar’s oncology expertise spans a wide range of cancers, with a particular focus on advanced radiation treatments. His specialty areas include colon cancer, rectal cancer, small intestine cancer, gallbladder cancer, stomach cancer, breast cancer, bowel cancer, throat cancer, and laryngeal cancer. Dr. Inbar is well-known for pioneering innovative radiotherapy strategies that improve patient outcomes, with over 350 research articles published on these techniques. His dedication to complex oncological diseases and his active membership in prestigious organizations such as the European Society of Mastology and the American Society of Clinical Oncology highlight his commitment to excellence. Serving as a senior consultant and educator, Dr. Moshe Inbar continues to influence cancer care practices internationally. His expertise at Hadassah University Hospital positions him as one of Israel’s best and most trusted oncologists for radiation oncology and cancer treatment.